Jaguar Health Files New Animal Drug Application For Full FDA Approval Of Canine Diarrhea Therapy

MT Newswires Live06-23

Jaguar Health (JAGX) completed the submission of its new animal drug application to the US Food and Drug Administration's Center for Veterinary Medicine, seeking full approval for crofelemer to treat chemotherapy-induced diarrhea in dogs, the company said Tuesday.

The application incorporates findings from a clinical efficacy study in veterinary oncology centers alongside data involving subjects undergoing targeted tyrosine kinase inhibitor therapies, the company said.

The medication operates as a non-antibiotic treatment mechanism and currently holds conditional agency approval for the canine indication, Jaguar Health said.

Shares of the company were down 1.6% in early Tuesday trading.

Price: 2.57, Change: -0.04, Percent Change: -1.61

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2645834601?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-23 21:54","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2645834601","market":"sh","top_or_hot":-1,"title":"Jaguar Health Files New Animal Drug Application For Full FDA Approval Of Canine Diarrhea Therapy","media":"MT Newswires Live","content":"<html><body><p> Jaguar Health (JAGX) completed the submission of its new animal drug application to the US Food and Drug Administration's Center for Veterinary Medicine, seeking full approval for crofelemer to treat chemotherapy-induced diarrhea in dogs, the company said Tuesday.</p><p>The application incorporates findings from a clinical efficacy study in veterinary oncology centers alongside data involving subjects undergoing targeted tyrosine kinase inhibitor therapies, the company said.</p><p>The medication operates as a non-antibiotic treatment mechanism and currently holds conditional agency approval for the canine indication, Jaguar Health said.</p><p>Shares of the company were down 1.6% in early Tuesday trading.</p><p>Price: 2.57, Change: -0.04, Percent Change: -1.61</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Jaguar Health Files New Animal Drug Application For Full FDA Approval Of Canine Diarrhea Therapy</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJaguar Health Files New Animal Drug Application For Full FDA Approval Of Canine Diarrhea Therapy\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-06-23 21:54</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Jaguar Health (JAGX) completed the submission of its new animal drug application to the US Food and Drug Administration's Center for Veterinary Medicine, seeking full approval for crofelemer to treat chemotherapy-induced diarrhea in dogs, the company said Tuesday.</p><p>The application incorporates findings from a clinical efficacy study in veterinary oncology centers alongside data involving subjects undergoing targeted tyrosine kinase inhibitor therapies, the company said.</p><p>The medication operates as a non-antibiotic treatment mechanism and currently holds conditional agency approval for the canine indication, Jaguar Health said.</p><p>Shares of the company were down 1.6% in early Tuesday trading.</p><p>Price: 2.57, Change: -0.04, Percent Change: -1.61</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4585","symbol_name":"ETF&股票定投概念","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2645834601","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2645834601","pubTimestamp":1782222885,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Jaguar Health  completed the submission of its new animal drug application to the US Food and Drug Administration's Center for Veterinary Medicine, seeking full approval for crofelemer to treat chemotherapy-induced diarrhea in dogs, the company said Tuesday.The application incorporates findings from a clinical efficacy study in veterinary oncology centers alongside data involving subjects undergoing targeted tyrosine kinase inhibitor therapies, the company said.The medication operates as a non-antibiotic treatment mechanism and currently holds conditional agency approval for the canine indication, Jaguar Health said.Shares of the company were down 1.6% in early Tuesday trading.Price: 2.57, Change: -0.04, Percent Change: -1.61","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4585":"ETF&股票定投概念","LABU":"三倍做多标普生物-Direxion","BK4007":"制药","JAGX":"Jaguar Animal Health, Inc.","BK4588":"碎股"},"translate_title":"Jaguar Health提交新动物药物申请FDA全面批准犬类腹泻疗法","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LABU":1.5,"JAGX":1},"content_text":"Jaguar Health (JAGX) completed the submission of its new animal drug application to the US Food and Drug Administration's Center for Veterinary Medicine, seeking full approval for crofelemer to treat chemotherapy-induced diarrhea in dogs, the company said Tuesday.The application incorporates findings from a clinical efficacy study in veterinary oncology centers alongside data involving subjects undergoing targeted tyrosine kinase inhibitor therapies, the company said.The medication operates as a non-antibiotic treatment mechanism and currently holds conditional agency approval for the canine indication, Jaguar Health said.Shares of the company were down 1.6% in early Tuesday trading.Price: 2.57, Change: -0.04, Percent Change: -1.61","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2645834601","isCrawlerRequest":true}